Journal of Vaccines & Vaccination

5^th Asia Pacific Global Summit and Expo on Vaccines & Vaccination

July 27-29, 2015 Brisbane, Australia

Scientific Tracks Abstracts

• Rational vaccine design against complex pathogens in the OMICS era

  Denise L. Doolan

  PDF HTML

• Development of a passive RSV vaccine for infants as an alternative to maternal vaccination

  Filip Dubovsky

  PDF HTML

• A dendritic cell-targetted vaccine loaded with a glyceraldehyde-3-phosphate dehydrogenase peptide confers wide protection to listeriosis in susceptible and resistant mice

  Carmen Alvarez-Dominguez

  PDF HTML

• Development and assessment of multivalent recombinant vaccines for bovine respiration disease

  Timothy J Mahony

  PDF HTML

• Advax-adjuvanted killed Japanese encephalitis virus (JEV) vaccine is safe in pregnant mares and in foals and induces robust immunological memory

  Helle Bielefeldt-Ohmann1,2, Natalie A. Prow2,3, Wenqi Wang1, Cindy S.E. Tan2,3, Mitchell Coyle4, Alysha Douma4, Jody Hobson-Peters2,3, Lisa Kidd1, Roy A. Hall2,3 and Nikolai Petrovsky5,6

  PDF HTML

• Achievements and challenges in post-exposure vaccine development

  Yuzhang Wu

  PDF HTML

• Novel non-genetic approach to improve the tuberculosis vaccine BCG

  Zakaria Hmama

  PDF HTML

• Chikungunya virus vaccines?

  Andreas Suhrbier

  PDF HTML

• Kunjin replicon-based vaccine candidate against Ebola virus

  Alexander A Khromykh1, Oleg Pyankov2, Olivier Reynard3, Olga Pyankova2, Sergey A Bodnev2, Vladislav V Solodkyi2, Stepan A Pyankov2, Yin Xiang Setoh1, Valentina A Volchkova3, Alexander A Agafonov2, Andreas Suhrbier4 and Viktor E Volchkov3

  PDF HTML

• Future prospect of mosquito salivary components as novel target for vector based vaccine against Dengue: Molecular characterization of immunomodulatory protein from salivary glands of Aedes aegypti

  Kartika Senjarini and Rike Oktarianti

  PDF HTML

• Using carriage surveillance to show direct and indirect effects of pneumococcal conjugate vaccine

  Fiona Russell

  PDF HTML

• Recruitability and Retention: The Challenges of Vaccine Trial design

  Suzanne L. Elliott, Kerry Manton, Lis Gilmour, Sharon Rankine and Paul Griffin

  PDF HTML

• Reverse vaccinology approach for tick vaccine development

  Ala Lew-Tabor

  PDF HTML

• Nasal vaccine using nanoparticles against toxoplasma gondii infection: A mechanistic study

  Didier Betbeder

  PDF HTML

• Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines

  Charani Ranasinghe

  PDF HTML

• Antigen-displaying polyester particles manufactured by engineered bacteria

  Bernd Rehm

  PDF HTML

• Capsular polysaccharide loaded chitosan nanoparticles for mucosal immunization via respiratory tract against Klebsiella pneumonia

  Menon MD1, Jain RR1, Mehta MR1 and Bannalikar AR2

  PDF HTML

• Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered nanoliposomes against Group A streptococcus

  Nirmal Marasini, Ashwini Kumar Giddam, Khairunnisa Abdul Ghaffar, Michael Batzloffc, Michael Goodc, Mariusz Skwarczynskia, and Istvan Totha,b,

  PDF HTML

• A protective immune response using asymmetric multi-epitope self-adjuvanting lipopeptide vaccine model

  Sharareh Eskandari1, Rachel J Stephenson1, David Pattinson2, Bita Sedaghat1, Saranya Chandrudu1, Simon H Apte2, Denise L Doolan2 and Istvan Toth1

  PDF HTML

• Binding and immune modulation properties of mannosylated lipo-peptide vaccines

  Bita Sedaghat†, Rachel J. Stephenson†, Ashwini Kumar Giddam†, Sharareh Eskandari†, Simon Apte‡, David Pattinson‡, Denise Doolan‡, and Istvan Toth

  PDF HTML

• Best practice for communicating pertussis booster vaccine recommendations to new mothers: A randomised-control trial

  Hayles, E.H.1,2,3, Cooper, S.C.2,4, Wood, N.2,3, Sinn, J.H.K1,5 and Skinner, S. R2

  PDF HTML

• Liposomes as a delivery platform of vaccines against group a Streptoccocus

  Khairunnisa Abdul Ghaffar1, Nirmal Marasini1, Ashwini Kumar Giddam1, Mariusz Skwarczynski1 and Istvan Toth1,2

  PDF HTML

• Vaccine manufacturing and clinical trial services for diarrheal disease product development

  Rodolfo M. Alarcón

  PDF HTML

• Anti-cancer telomerase vaccines: Are they entering the age of maturity?

  Gilberto Filaci

  PDF HTML

• Impact of Myriad Decisions on Patent Eligibility of Biotechnology Inventions in Australia and the US.

  Simon Potter

  PDF HTML

• Silica nanocarriers for delivery of single dose – shelf stable nano vaccines

  N. Mitter1 and C. Yu2

  PDF HTML

• Rotavirus vaccines: Development, implementation and impact

  Julie E. Bines

  PDF HTML

• How promising is the development of a meningococcal semi-synthetic conjugate vaccine? - a case study

  Manoj Kumar Chhikara, Zimra Israel and Davinder Gill

  PDF HTML

• Non-targeted effects of childhood vaccines: Epidemiological evidence and emerging immunological mechanisms

  Katie Flanagan

  PDF HTML

• Key steps in moving a vaccine from proof of concept in mice to human clinical trials

  Mark Reid

  PDF HTML

• Use of system biology to identify genes associated with enhanced immunogenicity to a skin patch (nanopatch) delivered vaccine

  Germain J. P. Fernandoa, Hwee-Ing Nga, Ian H. Frazerb and Mark A. F. Kendalla

  PDF HTML

• Immunisation using microspheres of poly glycidyl methacrylate functionalized with MSA-2 peptide to protect cattle from babesiosis

  Manuel Rodriguez-Valle1, Monica Florin-Christensen2, Miriem Santander Borrego3, Bronwyn Venus1, Ezequiel Balmori1; Peter Rolls4, Nancy Phillips4 and Ala Lew-Tabor1,5

  PDF HTML

• A Novel Quantitative Fluorescence Spectroscopy Method to Estimate the Surfactant-Induced Split Ratio of Influenza Virus

  Veysel Kayser

  PDF HTML

• New adjuvant G3/DT induces protective T cell response with a split-virion influenza vaccine

  Fohlman J, Thunander M, Morein B and Friman G

  PDF HTML

• Enhanced immunogenicity of a vero cell-derived inactivated Japanese encephalitis vaccine formulated with advax adjuvant

  Hiroko Toriniwa1, Tetsuo Nakayama2, Nikolai Petrovsky3 and Tomoyoshi Komiya1

  PDF HTML